Drug Trial Radar · NCT07285044
The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas
Last checked: Nov 20, 2026Latest source record: Sep 30, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
27
Planned (sponsor's estimate)
Start
Dec 18, 2025
Primary completion
May 15, 2027
Study completion May 15, 2027
Sponsor
- Lead sponsor
- Mayo ClinicAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Dec 16, 2025
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This phase II trial studies whether providing cancer treatment in the home is preferred over the traditional clinic setting and if it improves treatment satisfaction in cancer patients living in the Florida Panhandle and surrounding areas. Typically, drug-related cancer care is provided at a medical center which causes patients to have to spend considerable time away from their family, friends, and familiar surroundings. This may add to the physical, emotional, social, and financial burden for patients and their families during this difficult time in their lives. The Cancer Connected Access and Remote Expertise (CARE) Beyond Walls (CCBW) program uses a specialized care team trained to provide cancer treatment in the patient's home setting. It is designed to support remote connection between the home health team and providers and Mayo clinic. This may be preferred over the traditional clinic setting which may improve treatment satisfaction in cancer patients living in the Florida Panhandle and surrounding areas.
Conditions
- Amyloidosis
- Basal Cell Carcinoma
- Biliary Tract Carcinoma
- Bladder Carcinoma
- Breast Carcinoma
- Cervical Carcinoma
- Colorectal Carcinoma
- Endometrial Carcinoma
- Fallopian Tube Carcinoma
- Gastroesophageal Junction Carcinoma
- Glioblastoma
- Head and Neck Carcinoma
- Hematopoietic and Lymphatic System Neoplasm
- Hepatocellular Carcinoma
- Hodgkin Lymphoma
- Lung Carcinoma
- Malignant Solid Neoplasm
- Mantle Cell Lymphoma
- Melanoma
- Merkel Cell Carcinoma
- Multiple Myeloma
- Myelodysplastic Syndrome
- Ovarian Carcinoma
- Pancreatic Carcinoma
- Primary Peritoneal Carcinoma
- Prostate Carcinoma
- Renal Cell Carcinoma
- Squamous Cell Carcinoma
- Urothelial Carcinoma
Interventions
Cancer Therapeutic ProcedureDrug
Receive in-home standard of care cancer-treatment
Cancer Therapeutic ProcedureDrug
Receive in-clinic standard of care cancer-treatment
Questionnaire AdministrationOther
Ancillary studies
Primary outcomes
What the sponsor says the trial is designed to measure.
- Patient preferences regarding location of cancer treatment deliveryTime frame: At 12 weeks
- Adverse Events Related to Location of TreatmentTime frame: Up to 9 months
- Incidence of avoidable acute care visits, emergency room visits, and hospitalizationsTime frame: Up to 24 weeks
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Mayo Clinic in Florida
Jacksonville, Florida · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.